| A | B | C | D | E | |
|---|---|---|---|---|---|
1 | Years of life lost (YLL) due to C19 | Optimistic | Central | Pessimistic | Source: |
2 | |||||
3 | Experts (just for reference) | ||||
4 | % of world infected | 20% | 40% | 60% | Prof. Lipsitch (Harvard) |
5 | # of infections | 1.5bn | 3.0bn | 4.6bn | World population * % of World infected |
6 | IFR | 0.10% | 0.23% | 0.36% | Oxford C19 Evidence Service |
7 | # of Deaths | 1.5m | 7.0m | 16.4m | Row 5 * 6 |
8 | |||||
9 | Metaculus Predictions (From 16/04) | ||||
10 | # of infections | 1.6bn | 638m | 219m | Metaculus |
11 | IFR - metaculus calculated | 0.03% | 0.24% | 3% | Row 13 / Row 10 |
12 | IFR - metaculus direct prediction | 0.04% | 0.7% | 1.2% | Metaculus |
13 | # of Deaths direct prediction | 479k | 1.6m | 7m | Metaculus |
14 | |||||
15 | % deaths of <40 year olds | 0.05% | 0.10% | 0.20% | COVID-19-related mortality by age groups in Europe: A meta-analysis |
16 | % deaths of 40-69 year olds | 10.3% | 12.8% | 15.6% | COVID-19-related mortality by age groups in Europe: A meta-analysis |
17 | % deaths of ≥ 70 year olds | 88.1% | 84.8% | 81.3% | COVID-19-related mortality by age groups in Europe: A meta-analysis |
18 | |||||
19 | World Life expectancy @ 20 | 57 | 57 | 57 | https://population.un.org/wpp/DataQuery/ |
20 | World Life expectancy @ 55 | 25 | 25 | 25 | https://population.un.org/wpp/DataQuery/ |
21 | Population weighted World life expectancy @ ≥ 70 | 11 | 11 | 11 | https://population.un.org/wpp/DataQuery/ |
22 | |||||
23 | Average years of life lost per C19 death | 12.5 | 12.9 | 13.4 | |
24 | |||||
25 | Years of life lost due to C19 | 6m | 20m | 87m | Row 13 * 23 |
26 | |||||
27 | Other diseases YYLs | ||||
28 | Cancer | 213m | 217m | 221m | Global Burden of Disease 2017 |
29 | Substance abuse | 12m | 13m | 14m | Global Burden of Disease Study |
30 | Diarrhea | 73m | 85m | 100m | Global Burden of Disease Study |
31 | |||||
32 | Costs | ||||
33 | World GDP/capita | ~$11K | ~$11K | ~$11K | http://statisticstimes.com/economy/gross-world-product-capita.php |
34 | GDP per capita paid per DALY | 1 | 2 | 3 | Cost Per Daly Averted in Low, Middle and High Income Countries: Evidence from Global Burden of Disease Study to Estimate the Cost Effectiveness Thresholds |
35 | $ Cost of C19 | 2439bn | 4979bn | 7612bn |